Back to Trials
NCT07258784Recruiting

RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

University of Maryland, Baltimore

Start Date

9/11/2025

Completion Date

12/31/2026

Summary

Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: * Patients with benign tracheal stenosis Exclusion Criteria: * Malignancy. active infection

Interventions

PROCEDURE

Biopsy or surgery

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Tracheal StenosisSubglottic Stenosis

Locations

University of Maryland

Baltimore, Maryland 21201

United States